Associate Professor, Internal Medicine, Mayo Medical School
Medicine/Pediatrics
Dr. William A. Faubion Jr., MD
|
|
Give Review
William Faubion is an expert in the field of Medicine/Pediatrics. He attended University of Texas Medical School. He has 1 awards "Regional Top Doctor". William A. Faubion Jr. is also published. He has 70 publications published. The lastest publication: "Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas.' William A. Faubion Jr., MD is registered with Medicare and accepts Medicare payments.
Publications
- O-015 YI Alterations in the FOXP3-EZH2 Pathway Associates with Increased Susceptibility to Colitis in Both Mice and Human.
- Krüppel-like factor KLF10 regulates transforming growth factor receptor II expression and TGF-β signaling in CD8+ T lymphocytes.
- Stem Cells for Murine Interstitial Cells of Cajal Suppress Cellular Immunity and Colitis Via Prostaglandin E2 Secretion.
- Idiopathic inflammatory demyelinating disease of the central nervous System in patients with inflammatory bowel disease: retrospective analysis of 9095 patients.
- Immunology of inflammatory bowel Disease and molecular targets for biologics.
- Liver Enzyme Elevations within Three Months of Diagnosis of Inflammatory Bowel Disease and Likelihood of Liver Disease.
- Exome Sequencing Identifies a Novel FOXP3 Mutation in a 2-Generation Family With Inflammatory Bowel Disease.
- Letter: effectiveness of split-dose certolizumab pegol for Crohn's Disease.
- EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) Study Identifies Fecal Calprotectin, Serum MMP9, and Serum IL-22 as a Novel Combination of Biomarkers for Cr...
- Cytomegalovirus infection of the ileoanal pouch: clinical characteristics and outcomes.
- A case of Esophageal pseudomembranes.
- The epidemiology of Clostridium difficile infection in children: a population-based study.
- Functional characterization of EZH2? reveals the increased complexity of EZH2 isoforms involved in the regulation of mammalian gene expression.
- Incidence, Clinical Characteristics, and Natural History of Pediatric IBD in Wisconsin: a Population-based Epidemiological Study.
- Outcomes of patients with microscopic colitis treated with corticosteroids: a population-based study.
- Validation of the ulcerative colitis colonoscopic index of severity and its correlation with Disease activity measures.
- Regulatory T cell kinetics in the peripheral blood of patients with Crohn's Disease.
- Duodenal Intraepithelial Lymphocytosis with Normal Villous Architecture in Pediatric Patients, 2000-2009: The Mayo Clinic Experience.
- Natalizumab for moderate to severe Crohn's Disease in clinical practice: The Mayo Clinic Rochester experience.
- Single-Incision Laparoscopic Colon and Rectal Surgery for Pediatric Inflammatory Bowel Disease and Polyposis Syndromes.
- Concomitant therapy with methotrexate and anti-TNF-alpha in pediatric patients with refractory crohn's colitis: a case series.
- Single molecule measurements of tumor necrosis factor α and interleukin-6 in the plasma of patients with Crohn's Disease.
- Measurement of Disease activity in ulcerative colitis: Interobserver agreement and predictors of severity.
- Benefit of computed tomography enterography in Crohn's Disease: Effects on patient management and physician level of confidence.
- Short CDAI: development and validation of a shortened and simplified Crohn's Disease activity index.
- Adalimumab for Crohn's Disease in clinical practice at Mayo clinic: the first 118 patients.
- SLAM is a microbial sensor that regulates bacterial phagosome functions in macrophages.
- Enhanced suppressive function of regulatory T cells from patients with immune-mediated Diseases following successful ex vivo expansion.
- The pathogen recognition receptor NOD2 regulates human FOXP3+ T cell survival.
- Retraction: Induction of a Th1 response from Th2-polarized T cells by activated dendritic cells: dependence on TCR:peptide-MHC interaction, ICAM-1, IL-12, and IFN-gamma.
- Clinical utility of measuring infliximab and human anti-chimeric antibody concentrations in patients with inflammatory bowel Disease.
- Recurrence and impact of postoperative prophylaxis in laparoscopically treated primary ileocolic Crohn Disease.
- Open-label study of adalimumab in patients with Ulcerative colitis including those with prior loss of response or intolerance to infliximab.
- Circulating and gut-resident human Th17 cells express CD161 and promote Intestinal inflammation.
- Small-bowel imaging in Crohn's Disease: a prospective, blinded, 4-way comparison trial.
- FOXP3 regulates TLR10 expression in human T regulatory cells.
- Induction of a Th1 response from Th2-polarized T cells by activated dendritic cells: dependence on TCR:peptide-MHC interaction, ICAM-1, IL-12, and IFN-gamma.
- A population-based study of the frequency of corticosteroid resistance and dependence in pediatric patients with Crohn's Disease and ulcerative colitis.
- Medical therapy for refractory pediatric Crohn's Disease.
- Step-up versus top-down: application of new biological agents in pediatric inflammatory bowel Disease.
- CD48 controls T-cell and antigen-presenting cell functions in experimental colitis.
- Ly9 (CD229)-deficient mice exhibit T cell defects yet do not share several phenotypic characteristics associated with SLAM- and SAP-deficient mice.
- Budesonide in the treatment of inflammatory bowel Disease: the first year of experience in clinical practice.
- Cutting edge: the SLAM family receptor Ly108 controls T cell and neutrophil functions.
- In vivo generation of oligoclonal colitic CD4+ T-cell lines expressing a distinct T-cell receptor Vbeta.
- Endoscopic factors in the diagnosis of Colorectal dysplasia in chronic inflammatory bowel disease.
- Natural killer T cells: dogs of war or defenders of peace?
- Colitis is associated with thymic destruction attenuating CD4+25+ regulatory T cells in the periphery.
- Cutting edge: the natural ligand for glucocorticoid-induced TNF receptor-related protein abrogates regulatory T cell suppression.
- Cystatin A expression reduces bile salt-induced apoptosis in a rat hepatoma cell line.
- Death receptors in liver biology and pathobiology.
- Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas.
- Probiotic therapy with E. coli for Ulcerative colitis: take the good with the bad.
- Clinical pharmacology of inflammatory bowel Disease therapies.
- Spinal cord surgery and galactorrhea: a case report.
- Development of chronic colitis is dependent on the cytokine MIF.
- Blocking inducible co-stimulator in the absence of CD28 impairs Th1 and CD25+ regulatory T cells in murine colitis.
- Review article: biological activity markers in inflammatory bowel Disease.
- Challenges in pediatric inflammatory bowel Disease.
- Biologics in inflammatory bowel Disease: how much progress have we made?
- Treatment of isolated gastric Crohn''s Disease with inhaled corticosteroids.
- Treatment of eosinophilic Esophagitis with inhaled corticosteroids.
- The natural history of corticosteroid therapy for inflammatory bowel Disease: a population-based study.
- Pediatric "PSC-IBD": a descriptive report of associated inflammatory bowel Disease among pediatric patients with psc.
- The cell surface receptor SLAM controls T cell and macrophage functions.
- Workshop report: prevention of postoperative recurrence in Crohn's Disease.
- Pediatric chronic Ulcerative colitis: does infliximab increase post-ileal pouch anal anastomosis complications?
- Endothelial cell toll-like receptor 4 regulates fibrosis-associated angiogenesis in the liver.
- Role for krüppel-like transcription factor 11 in mesenchymal cell function and fibrosis.
Schools
University Of Texas Medical School At Houston
University TexHermann Hospital
Mayo Clinic
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- Manometry
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
- Pediatric Gastroenterology
- Medicine/Pediatrics
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
Mayo School of Graduate Medical Education -
University of Texas Health Science Center -
University of Texas Medical School
Hospital
-
Mayo Clinic - Rochester, Minnesota
Helpful Reviews
Similar Doctors
|
|
Dr. Theresa L. Wampler, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David R. Deyle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Conor G. Loftus, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mounif M. El-Youssef, MD |
|
|
Dr. Nataliya Razumilava, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stephanie L. Hansel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Imad Absah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Natasha Chandok, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael D. Leise, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samar H. Ibrahim, MD |
|
|
Dr. Kenneth K. Wang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rayna M. Grothe, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raina Shivashankar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deborah K. Freese, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Santhi S. Vege, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeanne Tung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter J. Tebben, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory W. Munson, MD |
|
|
Dr. Frank A. Sinicrope, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Sapna P. Sadarangani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ishrat I. Mansuri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vijay Singh, MD |
|
|
Dr. Salim Hommeida, MD |